ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iyoda, A.
Right arrow Articles by Fujisawa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iyoda, A.
Right arrow Articles by Fujisawa, T.

Ann Thorac Surg 2004;78:1928-1931
© 2004 The Society of Thoracic Surgeons


Original Article: General Thoracic

Clinicopathological Analysis of Pulmonary Sclerosing Hemangioma

Akira Iyoda, MDa, Kenzo Hiroshima, MDb, Mitsutoshi Shiba, MDc, Yukiko Haga, MDa, Yasumitsu Moriya, MD, Yasuo Sekine, MDa, Kiyoshi Shibuya, MDb, Toshihiko Iizasa, MD, Takehiko Fujisawa, MDa,*

a Department of Thoracic Surgery, Chiba, Japan
b Department of Basic Pathology, Chiba University, Graduate School of Medicine
c Department of Thoracic Surgery, Kimitsu Chuo Hospital, Chiba, Japan

Accepted for publication May 12, 2004.

* Address reprint requests to Dr Fujisawa, Department of Thoracic Surgery, Chiba University, Graduate School of Medicine, Japan, 1–8–1, Inohana, Chuo-ku, Chiba 260–8670, Japan (E-mail: fujisawat{at}faculty.chiba-u.jp).

BACKGROUND: Sclerosing hemangiomas of the lung are uncommon tumors and are thought to be benign. However, the histogenesis and clinicopathological features of these tumors have not been elucidated.

METHODS: We analyzed the clinicopathological features of 26 sclerosing hemangiomas. The immunoreactivity for Ki-67 and p53 of sclerosing hemangiomas was determined and compared with that of pathological stage 1 pulmonary papillary adenocarcinomas.

RESULTS: The patients of sclerosing hemangioma were predominantly female. Eighteen patients were detected as a result of routine medical examinations and 15 were nonsmokers. Seven patients underwent tumor enucleation, 10 underwent a wedge resection, and 9 underwent a lobectomy. The mean tumor size was 2.2 cm (range 1 to 5 cm). Pathological findings demonstrated a papillary pattern in 23 cases, sclerotic pattern in 26 cases, hemorrhagic pattern in 22 cases and a solid pattern in 25 cases. Twenty-five cases had an excellent prognosis with no evidence of recurrence following surgery. However, 1 patient who had undergone a wedge resection developed a local recurrence and required an additional wedge resection. The Ki-67 labeling index of sclerosing hemangiomas was significantly lower than that of adenocarcinomas, whereas the Ki-67 labeling index of the recurrent case was 0.4%. No significant immunohistochemical staining for p53 was observed in sclerosing hemangioma cases.

CONCLUSIONS: Sclerosing hemangioma exhibits various histologic findings. Although we experienced one case with a recurrent tumor, sclerosing hemangiomas did not exhibit malignant behavior.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
Y Wang, S-D Dai, F-J Qi, H-T Xu, and E-H Wang
p53 protein expression and genetic mutation in two primary cell types in pulmonary sclerosing haemangioma
J. Clin. Pathol., February 1, 2008; 61(2): 192 - 196.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The Society of Thoracic Surgeons.